Riskpilot← Back to searchSign inGet full accessAfyx Capital ApS
APSActiveCVR 36981822Tuborg Havnepark 22, 5. tvActivities of holding companies · NACE 6421Est. 2015— employees
Revenue 2025
DKK -170K
+1% vs 2024
EBITDA margin
100.0%
-1% vs 2024
Equity ratio
91.0%
Financial strength
Net profit 2025
DKK 980K
-98% vs 2024
| Revenue | DKK -170K | +1% |
| EBITDA | DKK -170K | -1% |
| Net profit | DKK 980K | -98% |
| Total assets | DKK 80M | -15% |
| Equity | DKK 72,7M | -22% |
| Employees | — | — |
Legal name
Afyx Capital ApS
CVR number
36981822
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
7. august 2015
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er forskning og produktudvikling inden for kræftbehandling, passiv kapitalanbringelse i selskaber, at eje fast ejendom samt hermed beslægtet virksomhed
Address
Tuborg Havnepark 22, 5. tv
Phone
+4540539894
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -129 | -20 | -35 | -33 | -75 | -159 | -80 | -207 | -168 | -170 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -129 | -20 | -35 | -33 | -75 | -159 | -80 | -207 | -168 | -170 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -129 | -20 | -35 | -33 | -75 | -159 | -80 | -207 | -168 | -170 |
| Net financials | -142 | -273 | 98.626 | 64.834 | 66.396 | -110.370 | -42.308 | 5.511 | 63.272 | 1.149 |
| Profit before tax | -271 | -293 | 98.590 | 64.801 | 66.321 | -110.529 | -42.387 | 5.304 | 63.103 | 980 |
| Tax | -0 | -0 | -0 | 10.285 | 15.348 | -0 | -0 | -0 | -272 | -0 |
| Net profit | -271 | -293 | 98.590 | 54.516 | 50.973 | -110.529 | -42.387 | 5.304 | 63.375 | 980 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13.364 | 16.595 | 116.233 | 184.367 | 225.190 | 85.274 | 43.492 | 42.975 | 94.561 | 79.968 |
| Equity | -221 | -514 | 98.076 | 152.593 | 203.566 | 85.037 | 37.399 | 36.983 | 93.458 | 72.738 |
| Long-term debt | 12.941 | 16.479 | 17.545 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 644 | 629 | 612 | 21.489 | 21.625 | 237 | 6.093 | 5.992 | 1.103 | 7.230 |
| Total debt | 13.585 | 17.108 | 18.156 | 21.489 | 21.625 | 237 | 6.093 | 5.992 | 1.103 | 7.230 |
EBITDA margin
-16970500.0%
This company
15.8%
Market median
-107408328% vs market
20162025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20162025
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20162025
Net profit margin
97973700.0%
This company
8.1%
Market median
+1209551752% vs market
20162025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2015-08-07 – 2016-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Afyx Capital ApS 
BARKA Therapeutics ApSBoard members of Afyx Capital ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|